reSee.it - Related Video Feed

In this episode of the Sean Ryan Show, host Shawn Ryan interviews Dr. Michael Bagnell, a functional neurologist, about brain health, functional medicine, and various neurological conditions. Ryan discusses the frustrations many people face when seeking help from traditional doctors, emphasizing that functional medicine practitioners are more invested in patient health and education. Dr. Bagnell explains the importance of brain health and shares insights on preventing conditions like Alzheimer's and dementia. He discusses the significance of movement for maintaining cognitive sharpness and addresses short-term memory loss, which can be linked to various brain regions and conditions, including traumatic brain injuries (TBIs) and ADHD. He highlights the need for comprehensive assessments to understand individual brain health and the potential therapies available. The conversation shifts to the effects of psychedelics on brain function, with Dr. Bagnell noting their potential to alter the default mode network, which may help with memory retrieval and emotional recovery. He acknowledges that while psychedelics can be beneficial for some, they are not suitable for everyone and should be approached with caution. Ryan and Dr. Bagnell also discuss the impact of marijuana on anxiety and mood, with Dr. Bagnell emphasizing the need for careful consideration of its effects, especially regarding long-term use. He mentions the importance of understanding individual brain chemistry and the potential for addiction to substances, including social media, which can drive dopamine release and influence behavior. The discussion includes the long-term effects of COVID-19, particularly "long COVID," which can manifest as brain fog and other cognitive issues. Dr. Bagnell explains that the brain stem is often affected by the virus, leading to various symptoms that may require rehabilitation similar to physical injuries. They also touch on addiction, particularly in military personnel, and how the pursuit of dopamine can lead to addictive behaviors. Dr. Bagnell emphasizes the need for a holistic approach to treatment, considering the body, mind, and spirit in recovery processes. Finally, Dr. Bagnell introduces an innovative dolphin-assisted therapy program designed to help individuals with neurological conditions. He describes the therapeutic benefits of interacting with dolphins, which can provide emotional and cognitive support, enhancing overall well-being. Overall, the episode highlights the complexities of brain health, the potential of functional medicine, and the importance of personalized approaches to treatment and rehabilitation.

The episode centers on science-based meditation methods and their impact on the brain and body, emphasizing that even brief daily practice yields meaningful benefits. In randomized trials, beginning meditators who practice five minutes per day for 30 days report reductions in depression, anxiety, and stress, alongside increases in well-being and signs of reduced inflammation, such as lower IL-6. The conversation clarifies that meditation is not about stopping thoughts or achieving perpetual calm, but about observing stress and thoughts through a mindful stance that fosters resilience, focus, and peace outside formal practice. The guests discuss how different meditation techniques—open monitoring, focused attention, walking or eyes-open forms—produce distinct brain states and how these states may accumulate into longer-term traits through repeated practice. The concept “the after is the before for the next during” illustrates how a state change during practice can shift baseline brain functioning and subsequently influence future practice, emotions, and behavior. The discussion highlights that there is no one-size-fits-all approach; beginning meditators should start small to lower barriers, choosing the form that they can actually sustain daily, with informal practices (like mindful walking or situational moments of awareness) sometimes offering comparable benefits to seated sessions. The dialogue also covers the role of “meta-awareness,” prefrontal circuits, and networks involved in self-regulation, as well as how practices like loving-kindness or compassion training can boost social connection and reduce bias. A recurring theme is the pace and discipline required for lasting change: initial anxiety can rise as the mind reorganizes itself, likened to a lactate of the mind, but consistency yields deeper benefits over time. The guest notes that flourishing is trainable, contagious, and has social spillovers, illustrated by classroom studies where teachers’ well-being correlated with improved student math outcomes. The conversation also touches the potential integration of meditation with sleep tools, light-based therapies, and careful consideration of psychedelics, with emphasis on integration, safety, and the need for more rigorous training for psychedelic-guided experiences. Overall, the episode distills practical guidance: start small, find a sustainable form, cultivate awareness and compassion, and recognize that consistent practice shapes both brain function and daily life, including relationships, learning, and purpose.

Deardra Leeman, a woman in her 50s or 60s from the Bay Area, suffered from bipolar disorder and experienced a severe depressive episode that led to suicidal ideation. Her psychiatrist, having attended a talk by Dr. Williams on rapid-acting neurostimulation, reached out for help. Dr. Williams assessed her condition and recommended inpatient treatment due to the severity of her symptoms. Upon admission, Deardra was in a catatonic state, unable to communicate and exhibiting severe depression. Dr. Williams instructed her family to ensure her safety until treatment could begin. On the following Monday, Deardra underwent accelerated transcranial magnetic stimulation (TMS) therapy. Despite initial equipment issues, she was treated successfully with a second machine. Remarkably, within 24 hours, Deardra showed no signs of depression or suicidality, appearing completely normal. This rapid response is particularly notable in bipolar patients, where treatment can be effective in as little as a day. The average time for major depression patients to respond is around 2.6 days. Following her treatment, Deardra and her family became advocates for the therapy, helping to fund further research and trials. Deardra remained asymptomatic for about a year, requiring occasional "touch-ups" to maintain her mental health. Dr. Williams emphasized the potential of accelerated TMS to quickly alleviate severe depressive symptoms, particularly in treatment-resistant cases. The conversation then shifted to the underlying mechanisms of brain activity in depression. Dr. Williams discussed a study on resting state functional connectivity MRI, which examines how different brain regions activate in relation to each other. He explained that in healthy individuals, certain areas of the brain activate in a coordinated manner, while in depressed individuals, this timing can be disrupted, leading to a different pattern of brain activity. This disruption may serve as a biomarker for identifying patients who would respond to rapid-acting neurostimulation. Dr. Williams outlined the evolution of psychiatric treatment paradigms, moving from a focus on life experiences (Psychiatry 1.0) to chemical imbalances (Psychiatry 2.0), and now to a circuit-based understanding of mental health (Psychiatry 3.0). He argued that understanding mental health as a circuit problem rather than a chemical one empowers patients, as it suggests that interventions can rewire the brain's circuitry without relying solely on medications. The discussion also touched on the potential of ibogaine, a psychedelic compound, for treating conditions like PTSD and addiction. Dr. Williams noted that ibogaine has shown promise in alleviating withdrawal symptoms in opioid addiction and may have broader applications in treating various psychiatric disorders. He highlighted the need for further research to understand ibogaine's mechanisms and its potential role in a new era of psychiatric treatment. Overall, the conversation emphasized the rapid advancements in neurostimulation therapies and the potential for new treatment paradigms that prioritize brain circuitry over traditional chemical imbalance theories. The ongoing research aims to refine these approaches, ultimately improving outcomes for patients with severe mental health conditions.

In this episode of the Huberman Lab podcast, Andrew Huberman discusses the science of meditation, focusing on its effects on the brain and body, and how it can enhance various aspects of life such as mood, focus, and sleep. He emphasizes that meditation encompasses a wide variety of practices, not just the traditional sitting with closed eyes. Different forms of meditation can activate specific brain areas and lead to significant changes in mood and cognitive performance. Huberman highlights the importance of selecting a meditation practice that aligns with individual goals, whether that be improving focus, mood, or sleep. He explains the underlying biology of meditation, detailing how certain brain areas, such as the left dorsolateral prefrontal cortex, anterior cingulate cortex (ACC), and insula, are involved in interpreting bodily sensations and emotions. The interplay between these areas helps regulate our emotional responses and decision-making processes. He introduces the concepts of interoception (awareness of internal bodily states) and exteroception (awareness of external stimuli), explaining that meditation can shift focus between these two states. Huberman suggests that understanding where one falls on this continuum can help tailor meditation practices to individual needs. For instance, those who are more interoceptively aware may benefit from exteroceptive-focused meditations, while those who are more dissociative might need to engage more with their internal states. The podcast also discusses the potential for meditation to reduce sleep needs and enhance cognitive performance. Huberman mentions studies indicating that regular meditation can lead to significant improvements in mood and cognitive function, even with shorter durations of practice. He introduces the concept of yoga nidra and non-sleep deep rest (NSDR) as effective alternatives for enhancing sleep quality and reducing stress. Huberman concludes by encouraging listeners to experiment with different meditation practices, emphasizing the importance of consistency and self-awareness in developing a beneficial meditation routine. He suggests a specific meditation practice called Space-Time Bridging, which involves moving attention through various spatial and temporal focuses to enhance awareness and mindfulness. This practice aims to balance interoceptive and exteroceptive awareness, ultimately fostering a more adaptable and present state of mind.

In this podcast, neurologist Steven Laureys discusses the intersection of neuroscience and meditation, emphasizing the ongoing mystery of consciousness. Initially skeptical about mindfulness, Laureys shares how personal crises led him to explore meditation, ultimately prescribing it to patients. He highlights the importance of understanding that perceptions and emotions shape our reality, drawing parallels with stoicism and Viktor Frankl's ideas on response to adversity. Laureys explains the brain's networks involved in consciousness, noting that meditation trains attention and can lead to structural brain changes, enhancing emotional and attentional control. He emphasizes that meditation is accessible to everyone, regardless of their background, and should be integrated into education to address emotional well-being. He also discusses the experiences of patients in comas, challenging the binary view of consciousness and advocating for a deeper understanding of subjective experiences. Laureys encourages listeners to explore meditation as a personal journey, highlighting its potential to improve mental health and overall well-being. He concludes by inviting curiosity and motivation as essential elements for starting meditation.

Hypnosis isn’t losing control; it’s a precise brain state that teaches people to regulate mind and body. Three core mechanisms emerge: reduced activity in the dorsal anterior cingulate cortex, a node tied to attention and threat detection; increased functional connectivity between the dorsolateral prefrontal cortex and the insula, strengthening mind–body control; and inverse connectivity between the prefrontal cortex and the posterior cingulate, dampening the default mode network’s self-referential drift. Together they foster sharper focus, less salience-driven distraction, and better body awareness. Hypnosis is largely self-directed; induction is simple—a quick gaze upward, closed eyes, slow exhale, and a hand floating up. In hypnotizable individuals, this can happen within seconds, illustrating hypnosis as a trainable skill rather than a gimmick. Hypnotizability is a relatively stable trait, measured with a brief induction and scored, with long-term retest correlations indicating limited change. Clinically, hypnosis yields meaningful analgesia and stress reduction. In catheter-based procedures, patients’ pain dropped from about five to one, anxiety from five to zero, and opioid use halved, with faster recovery as a result of reduced distress. Remote self-hypnosis apps yield similar benefits for pain and stress, and can help chronic pain management. Hypnosis also supports smoking cessation, with randomized data showing a subset stopping after one session and many reducing cigarette use substantially; there are vivid patient stories of surprising improvements. Genetics play a role: a COMT variant modulates dopamine metabolism and appears to influence hypnotizability, while imaginative involvement and dissociative histories increase susceptibility. Personality patterns matter too—more organized, rational individuals may be less hypnotizable, whereas creative or imaginative people tend to respond more readily. Techniques range from direct inductions to using self-hypnosis to focus on body relations and breathing. Beyond pain and habit change, hypnotic work raises questions of agency, trauma, and social influence. It can reframe self-narratives, helping survivors process abuse or guilt, though concerns about coercion exist. Breath work complements hypnosis, accelerating relaxation and easing transitions into hypnotic states; cyclic sighing and paced breathing can lower anxiety and support sustained practice. The discussion also situates hypnosis alongside other altered states that suppress the default mode network, including meditation and psychedelics, highlighting a continuum of tools for attention, emotion regulation, and pain relief. In sum, hypnosis engages robust brain networks to reduce arousal, reshape perception, and expand personal agency when guided with care and integrated with other modalities.

In this episode of Huberman Lab Essentials, Andrew Huberman discusses major depression, which affects 5% of the population and is the fourth leading cause of disability. Symptoms include grief, sadness, anhedonia (lack of pleasure), and vegetative symptoms like exhaustion and disrupted sleep. Major depression is linked to imbalances in norepinephrine, dopamine, and serotonin. Treatments include tricyclic antidepressants, SSRIs, and emerging therapies like ketamine and psilocybin, which show promise in rewiring neural circuits. Lifestyle interventions such as exercise, cold exposure, and dietary changes (like increasing EPA intake) can also help manage symptoms. Huberman emphasizes the importance of understanding depression's biological underpinnings and the need for personalized treatment approaches.

Welcome to the Huberman Lab Podcast. I'm Andrew Huberman, a Professor of Neurobiology and Ophthalmology at Stanford. This month, we’re focusing on mood disorders, including depression, attention deficit disorders, eating disorders, schizophrenia, and bipolar disorder. We will explore the psychological and biological underpinnings of these disorders, discussing treatments and behavioral tools like exercise, meditation, and prescription drugs. Many mood disorders share common pathways, often involving the same neurochemicals or neural circuits. Understanding one mood disorder can provide insights into others. A key concept is the pleasure-pain balance, discussed with Dr. Anna Lembke, which describes how the brain's pleasure system is linked to mental anguish. When we pursue pleasure, dopamine is released, increasing motivation. However, this pursuit can lead to a tipping of the balance toward pain, resulting in cravings and potentially addiction. To reset this balance, one must engage in activities that do not seek immediate pleasure, allowing for a healthier pursuit of enjoyment. Today, we will discuss major depression, distinct from bipolar depression, which is characterized by manic highs followed by lows. Major depression affects about 5% of the population and is a leading cause of disability. Accurate diagnosis should be performed by a qualified healthcare professional, as many people misuse the term "depression" to describe temporary sadness. Clinical depression is marked by grief, sadness, anhedonia (lack of pleasure), guilt, and vegetative symptoms like fatigue and sleep disturbances. These symptoms can disrupt the autonomic nervous system, leading to changes in appetite and sleep patterns. The architecture of sleep is notably altered in depression, with disruptions in slow-wave and REM sleep. The biology of depression involves three major neurochemical systems: norepinephrine, dopamine, and serotonin. Norepinephrine relates to lethargy, dopamine to pleasure and motivation, and serotonin to grief and cognitive aspects of depression. Treatments include tricyclic antidepressants, MAO inhibitors, and SSRIs, which increase serotonin efficacy but can have varying effects and side effects. Emerging treatments include ketamine and psilocybin, which target the NMDA receptor and promote neuroplasticity. Ketamine can provide rapid relief from depressive symptoms, while psilocybin shows promise in clinical trials for major depression, with significant improvements reported in many patients. Lifestyle changes can also help manage depression. Regular exercise and a diet rich in omega-3 fatty acids (particularly EPA) can reduce inflammation and improve mood. The ketogenic diet may also benefit those with treatment-resistant depression by enhancing GABA transmission. In summary, managing depression involves understanding its biological basis, recognizing symptoms, and exploring various treatment options, including lifestyle changes and emerging therapies. Thank you for joining me in this exploration of depression and its complexities.

Move isn't just a workout; it's a key that unlocks sharper thinking, deeper sleep, stronger skin, and a more resilient body. The conversation centers on ten unexpected benefits of exercise, underscoring that the brain responds to physical demand as a central nervous system organ, not a separate bystander. The speakers emphasize that strength training, through diverse movements and insulin sensitivity, drives cognitive gains, faster processing, and durable neural networks, with BDNF as the brain's natural fertilizer. They outline sleep as one of the most reliable benefits when training intensity is appropriate, noting deeper sleep and quicker onset in many, while warning against overtraining. Skin quality also improves with exercise, especially collagen production from strength work, and the same signals that strengthen muscles reach the skin. A dual effect on chronic pain emerges: corrected movement reduces pain, and repeated exposure to manageable discomfort increases pain tolerance, reconfiguring the brain's association with pain. Depression and anxiety figures prominently, with exercise described as at least equal to, and sometimes superior to medications and talk therapy for mild to moderate cases. The conversation cites a landmark study of more than 100,000 people where physical activity outperformed traditional treatments, while underscoring that starting small—an easy walk—can unlock momentum. They also connect exercise to gut health, immune resilience, and disease resistance, explaining that a fit body carries signals that support a calmer mind and steadier mood. Discipline emerges as another payoff: regular practice strengthens delayed gratification, a trait entrepreneurs reportedly share with high achievers, and it bleeds into work and finances. The discussion notes improvements in sexual health through better circulation and hormones, and points to studies linking muscular health with erectile function. The overall arc presents exercise as a catalyst for resilience—physical, mental, and social—able to improve life quality across several domains. Beyond the gym floor, the conversation wanders into technology and ethics: Can exogenous tools ever trump real movement, or should they complement it? They touch on futuristic biotech—including skin-modulating peptides and even a provocative discussion of a pregnancy robot and AI in therapy—invoking moral questions about how science can and should shape human life. They also note a link between fitness and entrepreneurship, observing that many successful founders exercise, a pattern framed as discipline translating into business performance.